[Your role / profession]
- A Computer Engineering student and aspiring AI/ML researcher deeply interested in longevity science, aging biology, healthspan extension, and the application of artificial intelligence to aging research
[Keep]
- Major new research findings on the biology and mechanisms of aging
- Clinical trial results involving interventions targeting aging or age-related biological processes
- Breakthroughs in partial cellular reprogramming, epigenetic rejuvenation, senolytics, rapamycin, NAD+ metabolism, gene therapy, and regenerative medicine
- Research on biological age, epigenetic clocks, aging biomarkers, and multi-omics approaches including genomics, transcriptomics, proteomics, and methylation
- Advances in AI/ML specifically applied to aging biology mechanisms, biological age prediction models, longevity drug discovery, or geroscience research (not general disease diagnostics)
- Important datasets, computational tools, models, or open-source projects relevant to aging biology and longevity research
- News from major longevity companies, research labs, startups, and prominent researchers
- FDA approvals, major clinical milestones, significant funding rounds, or major partnerships related to longevity biotechnology
- High-quality systematic reviews, meta-analyses, and landmark papers on aging and longevity interventions
- Major discoveries related to lifespan extension, healthspan improvement, cellular senescence, age-related diseases, and mechanisms of rejuvenation
[Filter out]
- Generic wellness, diet, exercise, or lifestyle advice without strong scientific relevance to aging research
- Marketing content for supplements, anti-aging products, or treatments without solid clinical evidence
- Celebrity anti-aging routines, beauty industry news, skincare trends, or cosmetic procedures
- Sensationalized longevity claims without credible scientific evidence
- Low-quality studies, press releases that exaggerate findings, or purely speculative anti-aging content
- Diagnostic tools, imaging platforms, or AI applications for age-related diseases (e.g. Alzheimer's, cancer) that focus on detection/diagnosis rather than aging mechanisms or longevity interventions
篩選嚴格度80
翻譯成
來源 (3)
我們現在支援更多動態網頁與 UGC 網站。如果您遇到某些來源無法抓取的問題，請在 Discord 上告訴我們。
MitoRx Therapeutics will present preclinical data on its lead asset MTRX31 at the 62nd annual meeting of the European Association for the Study of Diabetes in Milan from 28 September to 2 October 2026. Presenter Xavier Jacq will conduct an oral session on 30 September 2026 in Warsaw titled "MTRX31 i…
Loyal reported that LOY-003 completed the Reasonable Expectation of Effectiveness section of its Expanded Conditional Approval application with the U.S. FDA for a daily pill aimed at extending healthy lifespans in large and giant breed dogs. Consequently, all three lifespan extension candidates in L…
Eisai has received regulatory approval in Japan for Leqembi Pen, a subcutaneous autoinjector formulation for the treatment of early Alzheimer’s disease. The product allows patients or care partners to self-administer two injections totaling 500 mg once weekly at home, complementing the existing intr…
The Cat Health Company (TCHC) reported that PURR-001, an investigational treatment for age-related muscle loss in cats, increased body mass and muscle thickness in a 12-week, double-blind, placebo-controlled multi-site trial in Europe involving 35 geriatric cats. TCHC has also signed its first Europ…
Insilico Medicine has started a research program called Longevity Vaccines that uses generative AI, circular mRNA (cmRNA), and in vivo T-cell engineering to target cellular drivers of age-related disease. The initiative will initially focus on immune system rejuvenation.
New York-based Elysium Health has launched The Elysium Longevity Institute (TELI), a physician-led clinical program designed to bring rigor to the longevity field.
A $71 million cell and gene therapy facility has opened in Vilnius to manufacture patient-by-patient treatments, including production runs for single individuals. The facility also has ambitions in longevity medicine.